Morning Hubsters. John R Fischer here with the US Wire from the New York newsroom.
A product is only as good as its marketing strategy, a universal truth across all industries, including pharma and life sciences. As a result, PE firms such as Odyssey Investment Partners, Permira and Stella Point Capital are pursuing investments in marketing agencies focused on these sectors. I’ve got a listicle of five deals that highlight this trend.
We’ll finish with Friday Focus, where I’ll provide insights on a home care merger between a company backed by Berkshire Partners and one backed by The Vistria Group.I’ll also highlight other recent home care deals PE Hub has covered. Let’s dive in.
Selling to patients
Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging of the population, the increased prevalence of chronic disease and the growing complexity and specialization of the treatments themselves. Private equity firms have been snatching up companies that aim to accelerate the commercialization of treatments.
I rounded up five pharma marketing deals from the last five months.
To learn which firms are making deals in the segment, take a look at the premium Wire.
Friday Focus
Forcura, a workflow management company backed by Berkshire Partners, has merged with Medalogix, a software provider backed by The Vistria Group, to form a post-acute technology company focused on home care.
Here are some of the home care deals PE Hub has covered in 2025:
For my insights on the merger and more, check out the full Wire coverage.
That’s it for me. As always, if you have any questions, thoughts or want to chat, please email me at [email protected].
Nina Lindholm will bring you the Europe Wire on Monday, and MK Flynn will be in the US chair.
Cheers,
John
Read the full Wire commentary on PE Hub ...